Search
for
Sort by
Research 61–90 of 1000+
- Metabolic Aspects of Polycystic Ovary Syndrome
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Relationship Between Steroid Hormones and Metabolic Profile in Women With Polycystic Ovary Syndrome
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Comparison of Endocrine and Metabolic Profile of Obese and Lean PCOS Women with Infertility
- Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection
- Elevated serum chromogranin A levels are independently associated with metabolic and inflammatory disturbances in polycystic ovary syndrome
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Impaired metabolic effects of metformin in men with early-onset androgenic alopecia
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate (DHEA-S) in the majority of the alopecia areata patients: Is it a primitive and pathogenic perturbation of hypothalamic-pituitary-adrenal axis?
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- SERUM-CONCENTRATIONS OF DEHYDROEPYAN- DROSTERONE-SULFATE IN MEN WITH ANDROGE- NETIC ALOPECIA
- SERUM-CONCENTRATIONS OF Dehydroepyandrosterone-sulfate IN MEN WITH ANDROGENETIC ALOPECIA
- SERUM-CONCENTRATIONS OF Dehydroepyandrosterone-sulfate IN MEN WITH ANDROGENETIC ALOPECIA
- Influence of finasteride treatment on metabolic profile of men with androgenetic alopecia
- Comparison differentiated osteoblast from adipose stem cells and normal osteoblast
- Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS)
- ADRENAL ONCOCYTOMA IN CHILDREN – case report
- Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making
- Combinatorial Biosynthesis of Sulfated Benzenediol Lactones with a Phenolic Sulfotransferase from Fusarium graminearum PH-1
- Diagnosis of hyperandrogenism: Biochemical criteria
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Metabolites from Macroalgae and Its Applications in the Cosmetic Industry: A Circular Economy Approach
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Test With Oral Administration of Clomiphene May Add to Differential Diagnosis of Severe Hyperandrogenism in Postmenopausal Women - A Case Report
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Is dehydroepiandrosterone a hormone?
- Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome